Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August-September 2014.

A strategic joint venture, MidaSol Therapeutics, has been launched by UK nanomedicine company Midatech and its partner, the US drug delivery firm MonoSol Rx, aimed at commercialising diabetes therapies jointly developed by the companies.

Midatech of the UK and US based Immunotope are to form a joint venture called Syntara to develop antigen-based products as immune therapies to treat chronic viral infections and certain cancers.